On August 5, 2024, Richard Gonzalez, CEO of AbbVie Inc (NYSE:ABBV), sold 66,500 shares of the company. The transaction was documented in a recent SEC filing. After this sale, the insider now owns 446,599 shares of AbbVie Inc.
AbbVie Inc (NYSE:ABBV) is a global, research-focused biopharmaceutical company committed to developing innovative, advanced therapies for some of the world’s most complex and critical diseases. The company’s mission is to pursue solutions that improve health outcomes and dramatically improve people’s lives.
Over the past year, Richard Gonzalez has sold a total of 487,961 shares and purchased no shares. This latest transaction continues a trend within the company, where there were 13 insider sales and no insider purchases over the past year.
AbbVie Inc. shares were trading at $186.52 on the day of the sale. The company has a market capitalization of approximately $331.12 billion. The stock’s price-to-earnings ratio is 61.90, well above the industry median of 22.545.
AbbVie Inc.’s GF Value is $142.93, which represents a Price to GF Value ratio of 1.3, indicating that the stock is significantly overvalued based on its GF Value.
The GF value is calculated by taking into account historical multiples such as price-to-earnings ratio, price-to-sales ratio, price-to-book ratio and price-to-free cash flow, along with a GuruFocus adjustment factor based on the company’s past earnings and growth as well as Morningstar analysts’ estimates of future business performance.
This sale by the insider may be of interest to current and potential investors as it provides insight into the insider’s view on the stock’s valuation and future prospects.
This article created by GuruFocus is intended to provide general insights and does not constitute tailored financial advice. Our commentary is based on historical data and analyst forecasts, uses an unbiased methodology and is not intended to serve as specific investment advice. It does not contain a recommendation to buy or sell any stock and does not take into account any individual investment objectives or financial circumstances. Our goal is to provide long-term, fundamental, data-driven analysis. Note that our analysis may not include the most recent, price-sensitive company announcements or qualitative information. GuruFocus does not hold a position in any stocks mentioned here.
This article first appeared on GuruFocus.
